+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounding antiangiogenic cancer therapy for animals



Compounding antiangiogenic cancer therapy for animals



International Journal of Pharmaceutical Compounding 9(3): 195-198




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052269310

Download citation: RISBibTeXText

PMID: 23924977


Related references

Antiangiogenic therapy: preclinical premise and promise: Biological Basis for Antiangiogenic Therapy, Milan, Italy, 810 November 1999. Molecular Medicine Today 6(5): 188-189, 2000

Compounding for cancer in companion animals: therapeutic options and case reports. International Journal of Pharmaceutical Compounding 13(1): 42-49, 2009

Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumour. Investigational New Drugs 28(2): 199-202, 2010

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests. International Journal of Pharmaceutical Compounding 14(2): 142-149, 2010

Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless arithmetic nullifies careful compounding". International Journal of Pharmaceutical Compounding 19(6): 444-446, 2016

Combination of photodynamic therapy and antiangiogenic therapy for the treatment of human breast cancer in nude athymic mice. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 291, 1996

Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2. International Journal of Pharmaceutical Compounding 11(4): 313-323, 2007

Cancer Drug Discovery and Development Series, 3; Antiangiogenic agents in cancer therapy. Teicher, B A Cancer Drug Discovery and Development Series, 3; Antiangiogenic agents in cancer therapy xiii+450p, 1999

From AACR—urological cancer Antiangiogenic therapy works in metastatic urothelial cancer. Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology) 9(6): 307-307, 2012

Current status and perspective of antiangiogenic therapy for cancer: urinary cancer. International Journal of Clinical Oncology 11(2): 90-107, 2006

Antiangiogenic therapy in cancer. Drugs of the Future 30(7): 695-706, 2005

Antiangiogenic cancer therapy. Seminars in Cancer Biology 14(2): 139-145, 2004

Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative study. Apmis 112(3): 201-209, 2004

Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy. Biochemical and Biophysical Research Communications 413(1): 128-135, 2011

Basics of sterile compounding: compounding by weight versus compounding by volume. International Journal of Pharmaceutical Compounding 18(2): 131-134, 2014